Duchenne's Muscular Dystrophy (DMD) Completed Phase 1 Trials for Deflazacort (DB11921)

Also known as: Duchenne's Muscular Dystrophy / Duchenne Muscular Dystrophy (DMD) / Duchenne Muscular Dystrophy / Muscular Dystrophy, Duchenne / Muscular dystrophy

IndicationStatusPhase
DBCOND0066749 (Duchenne's Muscular Dystrophy (DMD))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02295748An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability DeflazacortTreatment
NCT02251600A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular DystrophyBasic Science